This is not the most recent version of the article. View current version (31 MAY 2013)

Intervention Review

Rivastigmine for vascular cognitive impairment

  1. David Craig1,*,
  2. Jacqueline Birks2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 19 APR 2004

Assessed as up-to-date: 6 JUN 2006

DOI: 10.1002/14651858.CD004744.pub2


How to Cite

Craig D, Birks J. Rivastigmine for vascular cognitive impairment. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD004744. DOI: 10.1002/14651858.CD004744.pub2.

Author Information

  1. 1

    Queen's University Belfast, Department of Geriatric Medicine, Belfast, UK

  2. 2

    University of Oxford, Centre for Statistics in Medicine, Oxford, UK

*David Craig, Department of Geriatric Medicine, Queen's University Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast, BT9 7BL, UK. david.craig@qub.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004

SEARCH

This is not the most recent version of the article. View current version (31 MAY 2013)

  1. You have free access to this content

    Current Version

    Rivastigmine for vascular cognitive impairment

    Jacqueline Birks, Bernadette McGuinness and David Craig

    Article first published online: 31 MAY 2013 | DOI: 10.1002/14651858.CD004744.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Rivastigmine for vascular cognitive impairment

    David Craig and Jacqueline Birks

    Article first published online: 19 APR 2004 | DOI: 10.1002/14651858.CD004744.pub2

  2. Version 1

    Rivastigmine for vascular cognitive impairment

    D Craig and J Birks

    Article first published online: 19 APR 2004 | DOI: 10.1002/14651858.CD004744